Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(4)
Combination Therapy
Hepatitis C Virus
Rheumatoid Arthritis
sustained virologic response
Subscribe
Academic
Publications
Induction of clinical remission with adalimumab–methotrexate combination therapy in a patient with rheumatoid arthritis and concomitant hepatitis C virus infection
Induction of clinical remission with adalimumab–methotrexate combination therapy in a patient with rheumatoid arthritis and concomitant hepatitis C vi
Edit
Induction of clinical remission with adalimumab–methotrexate combination therapy in a patient with rheumatoid arthritis and concomitant hepatitis C virus infection
BibTex
|
RIS
|
RefWorks
Download
Osamu Noguchi
,
Yukio Gibo
The patient described here is a 49-year-old woman who had
hepatitis C virus
(HCV) infection and
rheumatoid arthritis
(RA). Her RA had been successfully managed with methotrexate for about 10 years. After a sustained
virological response
was achieved with interferon therapy, treatment with adalimumab was instituted. This resulted in a rapid and sustained remission that lasted for more than a year, without HCV reactivation. The results in this case suggest that a sequential strategy, with initial HCV clearance followed by the targeting of remission with biologics, may be a favorable option in patients with RA and concomitant HCV infection.
Journal:
Modern Rheumatology - MOD RHEUMATOL
, pp. 1-5
DOI:
10.1007/s10165-011-0469-9
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
www.springerlink.com
)
(
www.springerlink.com
)
References
(15)
Rheumatoid Arthritis Induced by α-Interferon Therapy
(
Citations: 14
)
E. Passos de Souza
,
P. Teles Evangelista Segundo
,
F. Freire José
,
D. Lemaire
,
M. Santiago
Journal:
Clinical Rheumatology - CLIN RHEUMATOL
, vol. 20, no. 4, pp. 297-299, 2001
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
(
Citations: 492
)
Paul Angulo
,
Jill C. Keach
,
Kenneth P. Batts
,
Keith D. Lindor
Journal:
Hepatology
, vol. 30, no. 6, pp. 1356-1362, 1999
Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values
(
Citations: 30
)
E. Inoue
,
H. Yamanaka
,
M. Hara
,
T. Tomatsu
,
N. Kamatani
Journal:
Annals of The Rheumatic Diseases - ANN RHEUM DIS
, vol. 66, no. 3, pp. 407-409, 2007
Sex and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000
(
Citations: 37
)
Junko Tanaka
,
Junko Kumagai
,
Keiko Katayama
,
Yutaka Komiya
,
Masaaki Mizui
,
Retsuji Yamanaka
,
Kou Suzuki
,
Yuzo Miyakawa
,
Hiroshi Yoshizawa
Journal:
Intervirology
, vol. 47, no. 1, pp. 32-40, 2004
The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of nonA, non-B hepatitis in a plasmapheresis centre
(
Citations: 34
)
C Datz
,
M Cramp
,
T Haas
,
O Dietze
,
H Nitschko
,
G Froesner
,
N Muss
,
F Sandhofer
,
W Vogel
Journal:
Gut
, vol. 44, no. 4, pp. 563-567, 1999